Lazard, Inc., a leading financial advisory firm, has entered into an agreement to acquire Campbell Lutyens, a UK-based private markets advisor specializing in fund placement and secondary advisory services. The deal is valued at approximately $575 million and includes potential additional performance-based consideration of up to $85 million over a multi-year period. While the close date has not been disclosed, it is anticipated that the transaction will be completed during calendar year 2026 pending regulatory approvals.
Campbell Lutyens, founded in 1988, offers primary fundraising and secondary advisory services across private equity, private credit, and infrastructure sectors. The acquisition aims to create a global leader in private capital advisory by integrating Campbell Lutyens' expertise with Lazard's existing private capital advisory group.
Deal structure and financing
The $575 million transaction will be funded through a combination of cash and deferred payments over two years. A portion of the consideration is subject to lock-up arrangements, ensuring long-term alignment between the acquirer and key employees of Campbell Lutyens. The acquisition's financing details remain undisclosed; however, given the size and strategic importance of the deal, it likely involves a mix of debt and equity. No specific bank advisors or leverage metrics were disclosed in the announcement.
Strategic context
Lazard's rationale for acquiring Campbell Lutyens is to strengthen its position as a leading global private capital advisory firm. The combination enhances Lazard’s capabilities by integrating Campbell Lutyens' expertise in secondary advisory and primary fundraising with Lazard's existing services, creating synergies across M&A, restructuring, and broader financial advisory practices.
Campbell Lutyens was motivated to divest due to the strategic alignment offered by Lazard. This partnership enables Campbell Lutyens to leverage Lazard’s extensive global network and resources while maintaining its independent advisory approach. The deal aligns with both firms' growth strategies and underscores their commitment to becoming a premier provider of comprehensive private capital advisory services.
Regulatory path
The transaction is subject to regulatory approvals in the United States and European Union, given the international scope of both Lazard and Campbell Lutyens. While specific remedies or timelines have not been announced, regulators are likely to scrutinize potential overlaps in service offerings, particularly within secondary advisory and fund placement sectors across North America and Europe.
Given the deal's value and the nature of financial services involved, antitrust authorities will assess competitive impacts on private capital advisory markets. The combined entity’s global reach and market share may require detailed filings under the Hart-Scott-Rodino Antitrust Improvements Act in the US and similar provisions within EU competition law.
The transaction is expected to close in 2026 after regulatory approvals, with both firms emphasizing the deal's accretive impact on earnings starting from 2027. The combined entity will operate as Lazard CL, reinforcing Lazard’s strategic vision for integrated private capital advisory services globally.